1. Allgaier, H.P., Deibert, P., Becker, G., and Blum, H.E., 1998, Hepatocellular carcinoma: non-surgical treatment. Schweiz Rundsch Med Prax87:1466–1470.
2. Anderson, W.F., 1984, Prospects for human gene therapy. Science226:401–409.
3. Anderson, S.C, Johnson, D.E., Harris M.P., Engler, H., Hancock, W., Huang, W.-M., Wills, K.N., Gregory, R.J., Sutjipto, S., Wen, S.F., Lofgren, S., Shepard, H.M., and Maneval, D.C., 1998, p53 Gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of recombinant adenovirus. Clin. Cancer Res.4:1649–1659.
4. Baba, M., Yamamoto, R., Iishi, H., and Tatsuta, M., 1997, Ha-ras mutations in N-nitrosomorpholine-induced lesions and inhibition of hepatocarcinogenesis by antisense sequences in rat liver. Int. J. Cancer72:815–820.
5. Barisani, D., Green. R.M., and Gollan, J.L., 1999, Genetic hemochromatosis: pathogenesis, diagnosis, and therapy. Dig. Dis.14(15):304–315.